Cline Christopher R. sold TVTX
September 2, 2026 · Form 4 insider transaction
Cline Christopher R. sold 642 shares of Travere Therapeutics, Inc. at $66.37 per share, a transaction worth $42.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.